Trials / Unknown
UnknownNCT03631368
Treatment of Hypertrophic Scars With Intradermal Botox
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Roy G. Geronemus, M.D. · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, open label, single center, self-controlled clinical study to demonstrate the safety and efficacy of intradermal botulinum toxin in treating hypertrophic scarring.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botox | Intradermal injection with Botox 100U/mL will be performed using a 25g needle. Each subject will receive three treatments spaced 1 month apart. |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2019-05-31
- Completion
- 2019-05-31
- First posted
- 2018-08-15
- Last updated
- 2018-09-26
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03631368. Inclusion in this directory is not an endorsement.